baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Citi Call 215 PGR 16.01.2025/ DE000KJ0SYD2 /

14/05/2024 19:40:11	Chg.-0.050	Bid09:00:02	Ask-	Underlying	Strike price	Expiration date	Option type
2.150EUR	-2.27%	2.100 Bid Size: 22,500	- Ask Size: -	Progressive Corporat...	215.00 USD	16/01/2025	Call

GlobeNewswire 05:15 PyroGenesis Announces 2024 First Quarter Results

GlobeNewswire 01:33 Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...

GlobeNewswire 14/05 Team, Inc. Reports First Quarter 2024 Results

GlobeNewswire 14/05 Fanatics Sportsbook Cheers on Justin Thomas in his Home State of Kentucky

GlobeNewswire 14/05 Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 14/05 scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 14/05 Norton Rose Fulbright strengthens intellectual property practice with patent lawyer trio

GlobeNewswire 14/05 89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associate...

GlobeNewswire 14/05 aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulm...

GlobeNewswire 14/05 Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...

GlobeNewswire 14/05 Troilus Announces Feasibility Study Results for the Gold-Copper Troilus Project: Outlines a Large Sc...

GlobeNewswire 14/05 Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th

GlobeNewswire 14/05 Galaxy Entertainment Group Selected Unaudited Q1 2024 Financial Data

GlobeNewswire 14/05 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...

GlobeNewswire 13/05 Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...

GlobeNewswire 13/05 BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...

GlobeNewswire 13/05 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...

GlobeNewswire 09/05 Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...

GlobeNewswire 09/05 Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...

GlobeNewswire 08/05 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...

GlobeNewswire 07/05 MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...

GlobeNewswire 06/05 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...

GlobeNewswire 04/05 The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats

GlobeNewswire 02/05 PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...

GlobeNewswire 01/05 Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...

Citi Call 215 PGR 16.01.2025/ DE000KJ0SYD2 /

If you wish to receive reply to your feedback, please provide your email address.